Tag: Phase II trials

Apitegromab Reduces Lean Mass Loss With Tirzepatide in EMBRAZE Phase 2 Trial

June 9, 2026

Apitegromab Reduces Lean Mass Loss With Tirzepatide in EMBRAZE Phase 2 Trial

Ciltacabtagene Autoleucel CAR T Therapy for High-Risk Smoldering Multiple Myeloma

April 21, 2026

Ciltacabtagene Autoleucel CAR T Therapy for High-Risk Smoldering Multiple Myeloma

Trabectedin and Irinotecan Combination Shows Promise for Ewing Sarcoma

April 16, 2026

Trabectedin and Irinotecan Combination Shows Promise for Ewing Sarcoma

Web Analytics Made Easy - Statcounter